Potential conflict of interest: Nothing to report.
EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma
Version of Record online: 27 MAR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 5, pages 1886–1899, May 2014
How to Cite
Pellegrino, R., Calvisi, D. F., Neumann, O., Kolluru, V., Wesely, J., Chen, X., Wang, C., Wuestefeld, T., Ladu, S., Elgohary, N., Bermejo, J. L., Radlwimmer, B., Zörnig, M., Zender, L., Dombrowski, F., Evert, M., Schirmacher, P. and Longerich, T. (2014), EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma. Hepatology, 59: 1886–1899. doi: 10.1002/hep.26954
Supported by the Deutsche Forschungsgemeinschaft DFG SFB/TRR77 (subprojects B4 to L.Z., B5 to R.P, B.R., P.S., T.L., Z2 to J.L.B.), Graduiertenkolleg 1172 to J.W. and M.Z., Ev168/2-1 to M.E, and Do622/2-1 to F.D.; National Institutes of Health grants R21CA131625 and R01CA136606 to X.C.; P30DK026743 for UCSF Liver Center; Siemens/DAAD Post Graduate Programme to V.K.; LOEWE initiative Oncogenic Signaling Frankfurt to M.Z. (funded by the Hessian Ministry of Higher Education, Research and the Arts; funding reference number III L 4-518/55.004 (2009)) and institutional funds of the Georg-Speyer-Haus by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK) to M.Z.
- Issue online: 23 APR 2014
- Version of Record online: 27 MAR 2014
- Accepted manuscript online: 28 NOV 2013 02:38AM EST
- Manuscript Accepted: 26 NOV 2013
- Manuscript Received: 11 DEC 2012
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.